link to homepage

Institute of Neuroscience and Medicine

Navigation and service


The institute's focus is on research fields that require the use of nuclear methods. These are in particular the development of new radiotracers for in vivo imaging using  Positron Emission Tomography (PET) or Single Photon Emission Computed Tomography (SPECT). The potential of these imaging techniques is in the noninvasive diagnosis of regional physiological dysfunctions before the disease is manifested morphologically in order to start with therapeutic actions at an early stage.


Non-standard radionuclides

The development of non-standard radionuclides deals with the handling of atomic nuclei at a cyclotron, the investigation of nuclear properties and the development of radiochemical procedures aiming at medical or scientific application. The spectrum of this work extends from experimental physics aspects to the radiochemical development of inorganic and organometallic materials. Non-standard radionuclides: Non-standard radionuclides …



The principal task of the research group "radiopharmacology" consists of pharmaco-physiological characterization of novel receptor ligands. The performed investigations range from receptor membrane assays or autoradiographic studies up to chemical analyses for the determination of their metabolism. Radiopharmacology: Radiopharmacology …

Radiotracerentwicklung Docking of an A2aAdoLigand in the A2aAdoR

Radiotracer development

The main research focus of the group “Radiotracer development” is on the development of receptorligands, particularly for the adenosinergic and dopaminergic system, with the aim of non-invasive imaging of these interesting biological targets with PET and SPECT. Radiotracer Development: Radiotracer development …


Radiopharmaceutical production

The main focus of radiopharmaceutical production at the INM-5 is on the preparation of clinical trials for the Positron Emission Tomography (PET). Furthermore, radiotracers are produced in high radioactivity amounts for animal experiments. Radiopharmaceutical production: Radiopharmaceutical production …